yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q41907687-2B555C21-B760-4C07-9841-D8E54FFC0A77
Q41907687-2B555C21-B760-4C07-9841-D8E54FFC0A77
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41907687-2B555C21-B760-4C07-9841-D8E54FFC0A77
Pharmacokinetic-pharmacodynamic target attainment analyses to evaluate in vitro susceptibility test interpretive criteria for ceftaroline against Staphylococcus aureus and Streptococcus pneumoniae.
P2860
Q41907687-2B555C21-B760-4C07-9841-D8E54FFC0A77
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41907687-2B555C21-B760-4C07-9841-D8E54FFC0A77
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fad37181deb15630d6541db56466e3dd83f9ce68
P2860
CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.